Literature DB >> 7965408

In situ localization of type III and type IV collagen-expressing cells in human diabetic nephropathy.

M S Razzaque1, T Koji, T Taguchi, T Harada, P K Nakane.   

Abstract

Nodular intercapillary glomerulosclerosis is the most typical lesion of diabetic nephropathy (DN) and is characterized by increased extracellular matrix (ECM) and amorphous masses of mesangial matrix. The local exaggeration of these deposits results in the formation of the typical diabetic nodule. To clarify the composition of the ECM of sclerotic lesions in DN, we investigated the distribution of type III and type IV collagens and their mRNAs by immunohistochemistry and in situ hybridization, respectively. In normal renal tissues, there was no intraglomerular immunostaining for type III collagen, while strongly positive staining was found in the extraglomerular interstitium. Positive immunostaining for type IV collagen was also present in the mesangium, glomerular basement membrane (GBM), Bowman's capsule, and the vascular pole of the normal glomerulus. In DN, the nodular lesions were negative for type III collagen and strongly positive for type IV collagen. On the other hand, in the late stage of global sclerosis, both type III and type IV collagens were diffusely present in the sclerotic matrix. To determine the origins of these type III and type IV collagens in the sclerotic matrix, in situ hybridization was performed, utilizing thymine-thymine (T-T) dimerized synthetic oligonucleotides complementary to either pro alpha 1(III) chain or pro alpha 1(IV) chain mRNAs as probes. The signals were detected by enzyme immunohistochemistry using an anti-T-T antibody. Intraglomerular cells (glomerular epithelial and mesangial cells) containing type III collagen mRNA were found in DN with sclerotic lesions, but not in normal glomeruli.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7965408     DOI: 10.1002/path.1711740209

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Renal Graft Fibrosis and Inflammation Quantification by an Automated Fourier-Transform Infrared Imaging Technique.

Authors:  Vincent Vuiblet; Michael Fere; Cyril Gobinet; Philippe Birembaut; Olivier Piot; Philippe Rieu
Journal:  J Am Soc Nephrol       Date:  2015-12-18       Impact factor: 10.121

2.  Mast cells and type VIII collagen in human diabetic nephropathy.

Authors:  B M Rüger; Q Hasan; N S Greenhill; P F Davis; P R Dunbar; T J Neale
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

3.  Increased expression of type III and type IV collagen in diabetic nephropathy.

Authors:  M S Razzaque; T Taguchi
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

4.  Expression of type III collagen mRNA in renal biopsy specimens of patients with idiopathic membranous glomerulonephritis.

Authors:  M S Razzaque; T Taguchi
Journal:  Clin Mol Pathol       Date:  1996-02

5.  Heat shock protein 47: a novel biomarker of phenotypically altered collagen-producing cells.

Authors:  Takashi Taguchi; Arifa Nazneen; Abdulmonem A Al-Shihri; Khadijah A Turkistani; Mohammed S Razzaque
Journal:  Acta Histochem Cytochem       Date:  2011-04-21       Impact factor: 1.938

6.  Solidified glomerulosclerosis, identified using single glomerular proteomics, predicts end-stage renal disease in Chinese patients with type 2 diabetes.

Authors:  Lijun Zhao; Fang Liu; Lin Li; Junlin Zhang; Tingli Wang; Rui Zhang; Wei Zhang; Xiaoyan Yang; Xiaoxi Zeng; Yiting Wang; Yucheng Wu; Hao Yang; Shisheng Wang; Yi Zhong; Huan Xu; Shanshan Wang; Ruikun Guo; Honghong Ren; Lichuan Yang; Baihai Su; Jie Zhang; Nanwei Tong; Xin J Zhou; Mark E Cooper
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

Review 7.  Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease.

Authors:  María M Adeva-Andany; Natalia Carneiro-Freire
Journal:  World J Diabetes       Date:  2022-07-15

Review 8.  Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.

Authors:  Camelia R Ban; Stephen M Twigg
Journal:  Vasc Health Risk Manag       Date:  2008
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.